Aubrey De Grey: Accelerating the Longevity Escape Velocity (LEV), mouse Trials, Yamanaka Factor -148 – YouTubehttps://www.youtube.com/watch?v=DHvoPlcWwg4 Episode summary The video features Aubrey De Grey, a scientist working on developing medical innovations that can postpone age-related…

Jake Wintermute is a Developer evangelist at Ginkgo bioworks.His mission is to grow the biotech ecosystem, to diversify the bioeconomy, and to provide education, documentation and support for developers bringing new projects to Ginkgo’s platform.

Michael Forrest is a Cambridge university biochemistry graduate. Ph.D. computer science. Founder CEO of Biophysical Therapeutics, which is focused on drugs and interventions to slow aging and promote longevity.

Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer’s disease and a therapeutic device to stop that disorder in its earliest stages.

Sebastian Brunemeier, Building Puerto Rico, Puerto Rico Money, ImmuneAGE Locations, Switzerland Benefits, Distributed Biotech, ChatGPT, vitaDAO, DAOs, Non-profit, Accredited Investors, Mental Energy, Ageism, Hopelessness, Downhill After 18, Psychometrics, Healthspan Capital, Mouse Bottleneck, Business Opportunity, Mouse Models, Synthetic Models, Age-related Diseases, Human vs Mice, Cloning, Reverse Yamanaka Factors, Progeria Cells, IP, Investing, Contracting Out, Matthew “Oki” O’Connor, Cyclarity, Cholesterol, Brain Aging, Bone Marrow Transplant, ImmuneAge Special Sauce, Competitors, Biobank, Missing Team Members, Books, Longevity Biotech Fellowship,